| Robert E Laclair, MD | |
|
2550 E Broadway St, Helena, MT 59601-4905 | |
| (406) 457-4180 | |
| Not Available |
| Full Name | Robert E Laclair |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 29 Years |
| Location | 2550 E Broadway St, Helena, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396700035 | NPI | - | NPPES |
| 00A941700 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | A94170 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Peters Hospital | Helena, MT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St. Peter's Health | 7911814926 | 161 |
News Archive
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.
To diagnose rheumatoid arthritis, antibodies to the amino acid citrulline are commonly measured. A new study from Uppsala University shows that a broad mix of different antibodies in the joints is the dominant factor that can be associated with severe inflammation and joint damage.
Stroke is a frequent and dreaded complication of atrial fibrillation. But predicting which of the estimated six million Americans with a-fib are at highest risk has long challenged physicians weighing stroke risk against the serious side effects posed by lifelong therapy with warfarin and other blood thinners.
Pain relief is big business - very big business - which is why Dr Adrian Mulholland in the School of Chemistry has just won an EPSRC Leadership Fellowship grant of nearly £1million, part of which will be used to further his research into designing drugs for pain relief. However, he never goes near a lab, doing it all from his computer.
According to a new report from the American Academy of Pediatrics (AAP), fevers alone are not a cause for intervention in children. Dr. Janice Sullivan, the lead author of the report says, "The focus should be on comfort and not on absolute temperature." That's because fever can be help fight illness, by slowing down the reproduction of bacteria and viruses or stimulating the body's immune response she explains. "That's a benefit of fever…and may shorten the time that your child remains ill," she adds.
› Verified 9 days ago
| Entity Name | St. Peter's Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205025145 PECOS PAC ID: 7911814926 Enrollment ID: O20031204001245 |
News Archive
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.
To diagnose rheumatoid arthritis, antibodies to the amino acid citrulline are commonly measured. A new study from Uppsala University shows that a broad mix of different antibodies in the joints is the dominant factor that can be associated with severe inflammation and joint damage.
Stroke is a frequent and dreaded complication of atrial fibrillation. But predicting which of the estimated six million Americans with a-fib are at highest risk has long challenged physicians weighing stroke risk against the serious side effects posed by lifelong therapy with warfarin and other blood thinners.
Pain relief is big business - very big business - which is why Dr Adrian Mulholland in the School of Chemistry has just won an EPSRC Leadership Fellowship grant of nearly £1million, part of which will be used to further his research into designing drugs for pain relief. However, he never goes near a lab, doing it all from his computer.
According to a new report from the American Academy of Pediatrics (AAP), fevers alone are not a cause for intervention in children. Dr. Janice Sullivan, the lead author of the report says, "The focus should be on comfort and not on absolute temperature." That's because fever can be help fight illness, by slowing down the reproduction of bacteria and viruses or stimulating the body's immune response she explains. "That's a benefit of fever…and may shorten the time that your child remains ill," she adds.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert E Laclair, MD Po Box 6369, Helena, MT 59604-6369 Ph: (406) 447-2823 | Robert E Laclair, MD 2550 E Broadway St, Helena, MT 59601-4905 Ph: (406) 457-4180 |
News Archive
Cerulean Pharma Inc., a leader in developing dynamically tumor-targeted nanopharmaceuticals, today announced that the first patient has been dosed in a Phase 1b/2a study of its lead product candidate, CRLX101, in combination with Avastin, in metastatic renal cell carcinoma (mRCC) patients. The company also announced the completion of enrollment of its randomized Phase 2 study in advanced non-small cell lung cancer.
To diagnose rheumatoid arthritis, antibodies to the amino acid citrulline are commonly measured. A new study from Uppsala University shows that a broad mix of different antibodies in the joints is the dominant factor that can be associated with severe inflammation and joint damage.
Stroke is a frequent and dreaded complication of atrial fibrillation. But predicting which of the estimated six million Americans with a-fib are at highest risk has long challenged physicians weighing stroke risk against the serious side effects posed by lifelong therapy with warfarin and other blood thinners.
Pain relief is big business - very big business - which is why Dr Adrian Mulholland in the School of Chemistry has just won an EPSRC Leadership Fellowship grant of nearly £1million, part of which will be used to further his research into designing drugs for pain relief. However, he never goes near a lab, doing it all from his computer.
According to a new report from the American Academy of Pediatrics (AAP), fevers alone are not a cause for intervention in children. Dr. Janice Sullivan, the lead author of the report says, "The focus should be on comfort and not on absolute temperature." That's because fever can be help fight illness, by slowing down the reproduction of bacteria and viruses or stimulating the body's immune response she explains. "That's a benefit of fever…and may shorten the time that your child remains ill," she adds.
› Verified 9 days ago
Dr. Tracy Brian Dill, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2550 E Broadway St, Helena, MT 59601 Phone: 406-457-4180 | |
Dr. Ashley Ann Coggins, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2475 E Broadway St, Helena, MT 59601 Phone: 406-442-2480 | |
John R Ribic, DO Nephrology Medicare: Medicare Enrolled Practice Location: 4119 Fox Hollow Dr, Helena, MT 59602 Phone: 406-227-1155 Fax: 406-227-1591 | |
Dr. William Nestor Fernandez, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2400 Gold Rush Ave, Helena, MT 59601 Phone: 406-465-6957 Fax: 406-443-3350 | |
Dr. Donald Roland Skillman, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 2475 E Broadway St, Helena, MT 59601 Phone: 406-457-4180 | |
Daniel E Hesskamp, MD Nephrology Medicare: Medicare Enrolled Practice Location: 3330 Ptarmigan Ln, Helena, MT 59602 Phone: 406-442-3570 Fax: 406-495-7910 | |
Carla M Kingsley, DO Nephrology Medicare: Accepting Medicare Assignments Practice Location: 4119 Fox Hollow Dr, Helena, MT 59602 Phone: 406-438-1250 Fax: 406-227-1591 |